You are using an older browser version. Please use a supported version for the best MSN experience.

Jim Cramer assesses recent acquisitions in AbbVie and Bristol-Myers

Jim Cramer breaks down large acquisitions that AbbVie and Bristol-Myers recently made and explains why he's recommending AbbVie as a buy.
image beaconimage beaconimage beacon